News | News By Subject | News by Disease News By Date | Search News

Tumor (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal     2/13/2017
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017     12/22/2016
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T?     10/20/2016
Daiichi Sankyo and Plexxikon Suspend Phase III Trial of Drug for Rare Tendon Cancer     10/19/2016
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR     4/25/2016
Kite Pharma (KITE) Cancer Therapy Responses in Solid Tumors Continued in Small Trial, NCI Review Halts Patient Enrollment     4/18/2016
Fluorescence Lighting Up Clinical Research     3/3/2016
Forty Seven Launches with Half of $75 Million Series A Backed by Google (GOOG) and 100+ Patents     2/26/2016
Analyst Questions High Cost of T Cell Therapies as Potential Frontline Treatment for Blood Cancers     2/25/2016
Armed with $50 Million from Google (GOOG), Celgene (CELG) and More, ARMO BioSciences Eyes Next-Gen Cancer Drug Combos     2/11/2016
Sneak Peak of Five Prime (FPRX)'s Prelim Phase I Tumor Data Leaves Investors Happy     1/22/2016
Analysts Take a Peek at Pfizer (PFE)'s 2015 Drug Sales, With a Few Surprises     12/31/2015
SoCal Biotech BioAtla Forges a $1 Billion Antibody Partnership with Pfizer (PFE)     12/9/2015
Daiichi Sankyo and Bay Area’s Plexxikon Inc. Win Breakthrough Tag for Pexidbartini     11/2/2015
Dako (A) Strikes Avelumab Pact with Pharma Giants Pfizer (PFE) and Merck & Co. (MRK)     9/25/2015

News from Around the Web
New Technique Provides Quick Tumor Diagnosis During Brain Surgeries, University of Michigan Study     2/9/2017
Miniature Brain And Skull Found Inside 16-Year-Old Girl's Ovary, Shiga Medical Centre Study     1/11/2017
How Strata Oncology Plans To Sequence 100K Tumors For Free     12/22/2016
SurgVision Displays Tumors During Surgery     12/14/2016
New Invention: An Implantable Capsule For Killing Tumors, Houston Methodist Research Institute Study     12/13/2016
Deep Learning Algorithms Applied to Tracking Tumor Development, Fraunhofer Institute For Medical Image Computing Study     11/16/2016
Excess Weight Linked To 8 More Cancers, Washington University School of Medicine Reveals     8/31/2016
Magnetic Bacteria Carry Anti-Cancer Drugs To Tumor, Polytechnique Montréal Nanorobotics Laboratory Study     8/23/2016
Patch Delivers Drug, Gene, And Light-Based Therapy To Tumor Sites, MIT Study     7/26/2016
"Smart" Nanoparticle Called Pearls A Promising Gem To Target, Treat Tumors, University of Toronto Study     7/25/2016
Brain Tumor Risk Linked To The Wealthier, Better-Educated, Study Published In BMJ     6/21/2016
Wireless Injectable Computer Could Deliver More Accurate Reading Of Tumor Pressure, University of Michigan Study     6/17/2016
New MRI Contrast Agent Spots Malignant Tissues, Tokyo Institute Of Technology Study     6/15/2016
Chemical 'Sponges' Designed To Soak Up Toxic Cancer-Fighting Drugs After Targeting Tumors, Lawrence Berkeley National Laboratory Reveals     6/8/2016
Portable Probes Hunt Down Cancer Cells During Surgery, University Hospital of Lausanne Study Reveals     6/8/2016

Press Releases
New England Biolabs, Inc. Release: New Publication Highlights DNA Damage As A Prevalent Source Of Errors In Public Cancer Databases     2/17/2017
Medtronic (MDT)'s OsteoCool RF Ablation System Receives Expanded Indication For Palliative Treatment Of Metastatic Bone Tumors     2/15/2017
New Technique Provides Quick Tumor Diagnosis During Brain Surgeries, University of Michigan Study     2/9/2017
FDA Lifts Clinical Hold on NW Bio (NWBO)'s Phase III Cancer Vaccine Trial     2/7/2017
Cannabics Pharma Announces Initial Commercialization Of Cannabinoids-Based Personalized Diagnostics For Cancer Patients     2/7/2017
Merck & Co. (MRK) Release: European Commission (EC) Approves KEYTRUDA (Pembrolizumab) For First-Line Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Have High PD-L1 Expression With No EGFR Or ALK Positive Tumor Mutations     2/1/2017
GenomeDx Biosciences Announces Research Collaboration With Astellas (ALPMY) To Identify Genomic Drivers Of Patient Response To XTANDI (Enzalutamide) Capsules     2/1/2017
Northwell Health Is First On Long Island To Acquire Synaptive Medical's Brightmatter Technology For Complex Brain Tumor And Spinal Surgery     1/31/2017
Cellectar Biosciences  (CLRB) Release: Company Announces Additional U.S. Patent Granted For CLR 131 And CLR 125 In A Broad Range Of Solid Tumors     1/24/2017
Elekta Release: New Data In The Journal Of Neurosurgery Reinforce Use Of Company's Gamma Knife In Hypofractionated Radiosurgery To Treat Large Or Complex Brain Tumors     1/24/2017
Mologen (MOLGF.PK) Release: Combination Data Of TLR9 Agonist Lefitolimod With Checkpoint Inhibitors In Preclinical Tumor Models     1/23/2017
Biocept, Inc. (BIOC) Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells     1/19/2017
Protagen AG Release: The German National Center For Tumor Diseases (NCT) Heidelberg And Company Investigate Responsiveness To Checkpoint Inhibitors In Melanoma     1/17/2017
Advanced Accelerator Applications Release: Biotech Announces The New England Journal of Medicine Publication Of Lutathera NETTER-1 Phase III Results     1/12/2017
Propanc Release: Company Receives Allowance Of Key Patent Application For Method Of Treating Solid Tumors In The U.S.     1/11/2017

//-->